Brief: Sedana Medical Q4 Net Result at SEK -38.1 Million
Feb 15 (Reuters) - Sedana Medical Q4 sales SEK 44.5 million. * Q4 EBITDA SEK -9.1 million * Q4 cash flow from operating activities SEK 8.8 million * Q4 adjusted EPS SEK -0.38 * Q4 net income SEK -38.1 million * Q4 EBIT margin -33%
Recent news on Sedana Medical AB (publ)
See all newsSweden's Sedana Medical Q3 sales rise as growth returns
Brief: Sedana Medical Announces PDUFA Target Action Date
Brief: Sedana Medical Announces FDA Acceptance For Review Of Its New Drug Application In U.S.
Sweden's Sedana Medical Q2 sales flat, EBITDA loss narrows
Brief: Sedana Medical Q2 EBITDA Loss Narrows To SEK 1.9 Mln